Literature DB >> 19638960

Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung.

David E Fein1, Maria P Limberis, Sean F Maloney, Jack M Heath, James M Wilson, Scott L Diamond.   

Abstract

Physicochemical properties of gene transfer vectors play an important role in both transduction efficiency and biodistribution following airway delivery. Adeno-associated virus (AAV) vectors are currently used in many gene transfer applications; however, the respiratory epithelium remains a challenging target. We synthesized two cationic sterol-based lipids, dexamethasone-spermine (DS) and disubstituted spermine (D(2)S) for pulmonary gene targeting. Scanning and transmission electron micrographs (TEM) confirmed that AAV/lipid formulations produced submicron-sized clusters. When AAV2/9 or AAV2/6.2 were formulated with these cationic lipids, the complexes had positive zeta potential (zeta) and the transduction efficiency in cultured A549 cells increased by sevenfold and sixfold, respectively. Transduction of cultured human airway epithelium with AAV2/6.2-lipid formulations also showed approximately twofold increase in green fluorescence protein (GFP) positive cells as quantified by flow cytometry. Intranasal administration of 10(11) genome copies (GC) of AAV2/9 and AAV2/6.2 coformulated with lipid formulations resulted in an average fourfold increase in transgene expression for both vectors. Formulation of AAV2/9 with DS changed the tropism of this vector for the alveolar epithelium, resulting in successful transduction of conducting airway epithelium. Our results suggest that formulating AAV2/9 and AAV2/6.2 with DS and D(2)S can lead to improved physicochemical characteristics for in vivo gene delivery to lung.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638960      PMCID: PMC2814396          DOI: 10.1038/mt.2009.173

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  38 in total

1.  The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9.

Authors:  Bassel Akache; Dirk Grimm; Kusum Pandey; Stephen R Yant; Hui Xu; Mark A Kay
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor.

Authors:  Christine M Fouletier-Dilling; Pablo Bosch; Alan R Davis; Jessica A Shafer; Steven L Stice; Zbigniew Gugala; Francis H Gannon; Elizabeth A Olmsted-Davis
Journal:  Hum Gene Ther       Date:  2005-11       Impact factor: 5.695

Review 3.  Adeno-associated virus serotypes: vector toolkit for human gene therapy.

Authors:  Zhijian Wu; Aravind Asokan; R Jude Samulski
Journal:  Mol Ther       Date:  2006-07-07       Impact factor: 11.454

4.  Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.

Authors:  S G Sumner-Jones; L A Davies; A Varathalingam; D R Gill; S C Hyde
Journal:  Gene Ther       Date:  2006-07-20       Impact factor: 5.250

5.  Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus.

Authors:  Judy N Chin; Michael J Rybak; Chrissy M Cheung; Paul B Savage
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

6.  Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.

Authors:  Maria P Limberis; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

7.  Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells.

Authors:  Sonia Bastonero; Myriem Gargouri; Sandrine Ortiou; Jean-Louis Guéant; Marc D Merten
Journal:  J Gene Med       Date:  2005-11       Impact factor: 4.565

Review 8.  pH-sensitive liposomes--principle and application in cancer therapy.

Authors:  H Karanth; R S R Murthy
Journal:  J Pharm Pharmacol       Date:  2007-04       Impact factor: 3.765

9.  Adeno-associated virus types 5 and 6 use distinct receptors for cell entry.

Authors:  Michael P Seiler; A Dusty Miller; Joseph Zabner; Christine L Halbert
Journal:  Hum Gene Ther       Date:  2006-01       Impact factor: 5.695

10.  Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway.

Authors:  Stephanie G Sumner-Jones; Deborah R Gill; Stephen C Hyde
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more
  9 in total

Review 1.  Biopolymers augment viral vectors based gene delivery.

Authors:  Balaji Balakrishnan; Ernest David
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

2.  Interaction of 3β-amino-5-cholestene with phospholipids in binary and ternary bilayer membranes.

Authors:  Max Lönnfors; Oskar Engberg; Blake R Peterson; J Peter Slotte
Journal:  Langmuir       Date:  2011-12-14       Impact factor: 3.882

3.  Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.

Authors:  Robert Bucki; Katarzyna Leszczynska; Fitzroy J Byfield; David E Fein; Esther Won; Katrina Cruz; Andrzej Namiot; Alina Kulakowska; Zbigniew Namiot; Paul B Savage; Scott L Diamond; Paul A Janmey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

4.  AAV's anatomy: roadmap for optimizing vectors for translational success.

Authors:  Angela M Mitchell; Sarah C Nicolson; Jayme K Warischalk; R Jude Samulski
Journal:  Curr Gene Ther       Date:  2010-10       Impact factor: 4.391

5.  Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections.

Authors:  Katarzyna Leszczynska; Dorota Namiot; Fitzroy J Byfield; Katrina Cruz; Malgorzata Zendzian-Piotrowska; David E Fein; Paul B Savage; Scott Diamond; Christopher A McCulloch; Paul A Janmey; Robert Bucki
Journal:  J Antimicrob Chemother       Date:  2012-11-07       Impact factor: 5.790

6.  Polymers for improving the in vivo transduction efficiency of AAV2 vectors.

Authors:  Gilles Moulay; Sylvie Boutin; Carole Masurier; Daniel Scherman; Antoine Kichler
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

7.  A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis.

Authors:  Wei Shao; Arghya Paul; Sana Abbasi; Parminder S Chahal; Jimmy A Mena; Johnny Montes; Amine Kamen; Satya Prakash
Journal:  Int J Nanomedicine       Date:  2012-03-23

8.  Removal of Endotoxin from rAAV Samples Using a Simple Detergent-Based Protocol.

Authors:  Liudmyla Kondratova; Oleksandr Kondratov; Ragy Ragheb; Sergei Zolotukhin
Journal:  Mol Ther Methods Clin Dev       Date:  2019-09-06       Impact factor: 6.698

9.  Self-complementarity in adeno-associated virus enhances transduction and gene expression in mouse cochlear tissues.

Authors:  Graham Casey; Charles Askew; Mark A Brimble; R Jude Samulski; Andrew M Davidoff; Chengwen Li; Bradley J Walters
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.